• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适应芬太尼时代的美沙酮诱导。

Adapting methadone inductions to the fentanyl era.

机构信息

Division of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States of America; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States of America; Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States of America.

出版信息

J Subst Abuse Treat. 2022 Oct;141:108832. doi: 10.1016/j.jsat.2022.108832. Epub 2022 Jun 27.

DOI:10.1016/j.jsat.2022.108832
PMID:35870437
Abstract

Since 2013, fentanyl and fentanyl analogs, which are significantly more potent than heroin, have been increasingly prevalent in the opioid drug supply. A need exists to adapt methadone dosing from opioid treatment programs (OTPs) in this era. Current methadone protocols at many clinics in the United States are based on expert consensus documents that were created prior to the introduction of fentanyl into the drug supply and are relatively conservative. To date, most OTP reform efforts have focused on relaxation of regulations for take-homes and have not addressed the need to adapt methadone induction schedules to be more rapid in the fentanyl era, as allowed by current regulations. Written by OTP and inpatient consult service addiction medicine physicians with expertise in OUD treatment from across the United States, the aims of the perspective piece are to: 1) highlight the need to improve OTP care by adapting methadone inductions to the fentanyl era, 2) cite emerging evidence for and examples of experiences of OTPs using more aggressive methadone inductions, and 3) call for research and updated guidelines on safety and best practices for methadone induction.

摘要

自 2013 年以来,芬太尼及其类似物(比海洛因效力强得多)在阿片类药物供应中越来越普遍。在这个时代,有必要调整美沙酮在阿片类药物治疗计划(OTP)中的剂量。目前,美国许多诊所的美沙酮方案都是基于在芬太尼进入药物供应之前制定的专家共识文件,这些文件相对保守。迄今为止,大多数 OTP 改革工作都集中在放宽家庭取药量的规定上,而没有解决在芬太尼时代需要更快地适应美沙酮诱导方案的问题,而目前的规定允许这样做。本文由美国各地 OTP 和住院咨询服务成瘾医学医师撰写,他们在治疗 OUD 方面具有专业知识,本文的目的是:1)强调需要通过使美沙酮诱导适应芬太尼时代来改善 OTP 护理,2)引用更多激进的美沙酮诱导方法的新兴证据和 OTP 经验的例子,3)呼吁进行研究并更新有关美沙酮诱导的安全性和最佳实践的指南。

相似文献

1
Adapting methadone inductions to the fentanyl era.适应芬太尼时代的美沙酮诱导。
J Subst Abuse Treat. 2022 Oct;141:108832. doi: 10.1016/j.jsat.2022.108832. Epub 2022 Jun 27.
2
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.美沙酮桥接门诊在阿片类药物戒断和阿片类药物治疗项目衔接中的应用:一个符合 72 小时规则的案例报告。
Addict Sci Clin Pract. 2021 Dec 28;16(1):73. doi: 10.1186/s13722-021-00279-x.
3
Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care.桥诊所在阿片类药物戒断管理中实施“72 小时规则”美沙酮:对阿片类药物治疗项目衔接和维持治疗的影响。
Drug Alcohol Depend. 2022 Jul 1;236:109497. doi: 10.1016/j.drugalcdep.2022.109497. Epub 2022 May 14.
4
In-Hospital Methadone Enrollment: a Novel Program to Facilitate Linkage from the Hospital to the Opioid Treatment Program for Vulnerable Patients with Opioid Use Disorder.住院美沙酮入组:一种为阿片类药物使用障碍的脆弱患者从医院到阿片类药物治疗项目进行衔接的新方案。
J Gen Intern Med. 2024 Feb;39(3):385-392. doi: 10.1007/s11606-023-08411-0. Epub 2023 Sep 15.
5
COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.美沙酮口服药物维持治疗点与 COVID-19 相关的政策变化:一项针对阿片类药物治疗项目领导层的多州调查。
Subst Abus. 2022;43(1):633-639. doi: 10.1080/08897077.2021.1986768. Epub 2021 Oct 19.
6
Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report.美沙酮诱导治疗在急诊科出现戒断症状的患者:病例报告。
J Addict Med. 2023;17(3):367-370. doi: 10.1097/ADM.0000000000001109. Epub 2022 Dec 23.
7
Characteristics and current clinical practices of opioid treatment programs in the United States.美国阿片类药物治疗计划的特点和当前临床实践。
Drug Alcohol Depend. 2019 Dec 1;205:107616. doi: 10.1016/j.drugalcdep.2019.107616. Epub 2019 Oct 17.
8
Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients.美沙酮监管对住院患者阿片类药物使用障碍治疗的意外后果。
J Hosp Med. 2024 Jun;19(6):460-467. doi: 10.1002/jhm.13329. Epub 2024 Mar 20.
9
Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic.损失、解放和能动性:新冠肺炎大流行期间阿片类药物治疗项目中美沙酮治疗患者的体验。
J Subst Use Addict Treat. 2024 Feb;157:209235. doi: 10.1016/j.josat.2023.209235. Epub 2023 Dec 5.
10
Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.在芬太尼时代(pRESTO),口服吗啡缓释剂与美沙酮治疗阿片类药物使用障碍的非劣效性随机临床试验方案。
Contemp Clin Trials. 2020 Apr;91:105993. doi: 10.1016/j.cct.2020.105993. Epub 2020 Mar 16.

引用本文的文献

1
Evaluation of a Novel Patient-Centered Methadone Restart Protocol.一种新型以患者为中心的美沙酮重新启动方案的评估
JAMA Netw Open. 2025 Aug 1;8(8):e2529393. doi: 10.1001/jamanetworkopen.2025.29393.
2
Hospital-Based Methadone and Buprenorphine Initiation Practices by Addiction Consult Services.成瘾咨询服务机构在医院开展美沙酮和丁丙诺啡起始治疗的实践情况
JAMA Netw Open. 2025 Aug 1;8(8):e2526077. doi: 10.1001/jamanetworkopen.2025.26077.
3
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial.
快速静脉注射症状抑制性芬太尼诱导法(SIFI),以优化使用非正规芬太尼者向口服阿片类激动剂疗法的转换:一项开放标签、单臂临床试验方案
Addict Sci Clin Pract. 2025 Jul 29;20(1):58. doi: 10.1186/s13722-025-00586-7.
4
Duration of Methadone and Buprenorphine-Naloxone Treatment.美沙酮及丁丙诺啡-纳洛酮治疗的持续时间。
JAMA Netw Open. 2025 Jul 1;8(7):e2518389. doi: 10.1001/jamanetworkopen.2025.18389.
5
Rapid Titration of Methadone for Opioid Use Disorder in the Emergency Department: A Case Report.急诊科美沙酮用于阿片类物质使用障碍的快速滴定:一例报告
Clin Pract Cases Emerg Med. 2025 May;9(2):188-192. doi: 10.5811/cpcem.39968.
6
Risk of Relapse Following Discharge from Non-Hospital Residential Opioid Use Disorder Treatment: A Systematic Review of Studies Published from 2018 to 2022.非医院住院阿片类物质使用障碍治疗出院后的复发风险:对2018年至2022年发表的研究的系统评价
Subst Abuse Rehabil. 2025 Apr 23;16:105-118. doi: 10.2147/SAR.S440214. eCollection 2025.
7
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015-2022.2015 - 2022年马里兰州巴尔的摩市注射吸毒者在新冠疫情期间的药物治疗及支持服务利用情况:一项中断时间序列分析
Int J Drug Policy. 2025 Apr;138:104746. doi: 10.1016/j.drugpo.2025.104746. Epub 2025 Mar 3.
8
Case series: Symptom-inhibited fentanyl induction (SIFI) onto treatment-dose opioid agonist therapy in a community setting.病例系列:在社区环境中,症状抑制性芬太尼诱导(SIFI)用于治疗剂量的阿片类激动剂疗法。
Am J Addict. 2025 May;34(3):355-360. doi: 10.1111/ajad.70011. Epub 2025 Feb 18.
9
"I still can feel the sickness": Withdrawal experiences of people on methadone maintenance treatment.“我仍能感觉到不适”:美沙酮维持治疗者的戒断经历
J Subst Use Addict Treat. 2025 Mar;170:209616. doi: 10.1016/j.josat.2024.209616. Epub 2024 Dec 23.
10
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.丁丙诺啡/纳洛酮与美沙酮治疗阿片类物质使用障碍的比较
JAMA. 2024 Dec 3;332(21):1822-1831. doi: 10.1001/jama.2024.16954.